UBE2S, ubiquitin conjugating enzyme E2 S, 27338

N. diseases: 42; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.010 Biomarker disease BEFREE Together, UBE2S could be a potential target for lung adenocarcinoma.[BMB Reports 2018; 51(12): 642-647]. 30545437 2018
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.010 AlteredExpression disease BEFREE Furthermore, knockdown of UBE2S expression inhibited NHEJ-mediated DSB repair and rendered glioblastoma cells more sensitive to chemotherapy. 27593939 2017
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.010 AlteredExpression disease BEFREE The UBE2S expression in PDAC was measured by immunohistochemistry and qRT-PCR. 31814735 2019
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.010 AlteredExpression disease BEFREE We demonstrated that overexpression of E2-EPF protein correlated with estrogen receptor (ER) negativity in breast cancer specimens and that its expression is cell cycle-regulated, suggesting a potential function for E2-EPF in cell cycle progression. 17710163 2007
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.010 Biomarker phenotype BEFREE Since UBE2S is an ubiquitin-conjugating enzyme and this enzyme activity is involved in DNA damage repair, HCV-infected cells are more sensitive to DNA damage, and thus UBE2S may contribute to viral oncogenesis. 30381483 2019
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.010 Biomarker disease BEFREE UBE2S might contribute to Hif-1α signaling in cervical cancer. 28277581 2017
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 Biomarker disease BEFREE UBE2S might contribute to Hif-1α signaling in cervical cancer. 28277581 2017
CUI: C0280474
Disease: Childhood Glioblastoma
Childhood Glioblastoma
0.010 AlteredExpression disease BEFREE Furthermore, knockdown of UBE2S expression inhibited NHEJ-mediated DSB repair and rendered glioblastoma cells more sensitive to chemotherapy. 27593939 2017
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.010 Biomarker disease BEFREE The findings in this study extend our mechanistic understanding of the mesoendodermal cell fate commitment, and provide UBE2S as a putative target for human CRC therapy. 29674637 2018
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.010 Biomarker disease BEFREE UBE2S mediates tumor progression via SOX6/β-Catenin signaling in endometrial cancer. 30690078 2019
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.020 Biomarker disease BEFREE Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer. 21912958 2012
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.020 Biomarker disease BEFREE However, the role of E2-EPF ubiquitin carrier protein (UCP) in esophageal cancer remains relatively unstudied. 19083192 2009
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms
0.020 Biomarker group BEFREE However, the role of E2-EPF ubiquitin carrier protein (UCP) in esophageal cancer remains relatively unstudied. 19083192 2009
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms
0.020 Biomarker group BEFREE Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer. 21912958 2012
CUI: C1275278
Disease: Extraskeletal Myxoid Chondrosarcoma
Extraskeletal Myxoid Chondrosarcoma
0.010 Biomarker disease BEFREE Collectively, these data suggest UBE2S may serve as a promising prognostic factor and function as an oncogene in EMC. 30690078 2019
CUI: C0017636
Disease: Glioblastoma
Glioblastoma
0.010 AlteredExpression disease BEFREE Furthermore, knockdown of UBE2S expression inhibited NHEJ-mediated DSB repair and rendered glioblastoma cells more sensitive to chemotherapy. 27593939 2017
CUI: C1621958
Disease: Glioblastoma Multiforme
Glioblastoma Multiforme
0.010 AlteredExpression disease BEFREE Furthermore, knockdown of UBE2S expression inhibited NHEJ-mediated DSB repair and rendered glioblastoma cells more sensitive to chemotherapy. 27593939 2017
CUI: C0017638
Disease: Glioma
Glioma
0.010 AlteredExpression disease BEFREE E2-EPF levels were low in normal brain tissue samples but high in glioma nuclei. 28384045 2017
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.010 Biomarker disease BEFREE Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression. 30903204 2019
CUI: C0019196
Disease: Hepatitis C
Hepatitis C
0.010 AlteredExpression disease BEFREE These data suggest that HCV counteracts antiviral activity of UBE2S to optimize viral propagation and may contribute to HCV-induced liver pathogenesis.<b>IMPORTANCE</b> Protein homeostasis is essential to normal cell function. 30381483 2019
CUI: C4722099
Disease: High grade glioma
High grade glioma
0.010 AlteredExpression disease BEFREE Ectopic E2-EPF levels in high-grade glioma were significantly higher than in low-grade glioma (p < 0.01). 28384045 2017
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.010 Biomarker group BEFREE Other dementia-related proteins, namely Tau and apoE, interact with and are ubiquitinated via the ACR in vitro This, and the evidence that CRBN and CUL4B are linked to intellectual disability, prompts us to hypothesize a pathogenic mechanism, in which APP acts as a modulator of E3 ubiquitin-protein ligase(s), shared by distinct neuronal disorders. 27325702 2016
CUI: C3665419
Disease: intracranial glioma
intracranial glioma
0.010 AlteredExpression disease BEFREE The aim of this study was to reveal how the level of E2-EPF relates to prognosis in brain glioma. 28384045 2017
CUI: C0220641
Disease: Lip and Oral Cavity Carcinoma
Lip and Oral Cavity Carcinoma
0.010 Biomarker disease BEFREE These findings might promote the understanding of the relationship between UBE2S overexpression and oral cancer proliferation, indicating that UBE2S would be a potential biomarker of and therapeutic target in OSCCs. 28257844 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.030 Biomarker disease BEFREE Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression. 30903204 2019